For Research Use OnlyNot for human consumptionThird-party HPLC testedPer-lot COA includedCold-chain dispatchedDiscreet packaging

Weight Management · 10mg / 20mg vials

Retatrutide

Retatrutide is a triple agonist targeting GLP-1, GIP, and glucagon receptors — the most comprehensive metabolic peptide currently in research. The glucagon receptor action adds fat oxidation and thermogenesis on top of the appetite suppression and insulin signaling of dual agonists.

Concentration reference

Standard mix: 10mg vial + 1mL BAC water = 10mg/mL. Each 0.1mL = 1mg (1,000mcg).

Dosing schedule

Phase / UseDoseDraw VolumeFrequencyNotes
Weeks 1–42mg0.2mL (20 IU)Once weeklyFoundational tolerance period — do not skip
Weeks 5–84mg0.4mL (40 IU)Once weeklyFirst escalation
Weeks 9–128mg0.8mL (80 IU)Once weeklySecond escalation — significant appetite reduction expected
Weeks 13–1612mg1.2mL — split across two drawsOnce weeklyResearch target dose for most protocols
Weeks 17+12–16mgAdjust proportionallyOnce weeklyMax studied dose range — advanced only

Reconstitution calculator

Concentration

Draw volume

On insulin syringe

U-100 insulin syringe: 1 mL = 100 IU. Calculation for research reference only.

Injection sites

Abdomen, outer thigh, upper arm. Rotate every injection.

Timing

Once weekly, consistent day. With or without food. Morning preferred.

Cycle length

16–24 weeks. 6–8 week recovery. The extended escalation schedule means this is a longer-term protocol than semaglutide.

Stacking

NAD+ for cellular energy support. CJC-1295 stack not typically combined — focus on metabolic outcomes.

Warnings

  • The 4-step escalation is mandatory — triple agonist activity amplifies GI effects if rushed
  • If any escalation step causes significant discomfort, hold for 4 extra weeks before proceeding

Tips

  • Triple agonist action means effects compound with each escalation more than other GLP peptides
  • Glucagon receptor activity can increase thirst — maintain higher fluid intake throughout protocol

Common stacks

Maximum weight loss

Triple agonist + cellular energy — most comprehensive metabolic protocol.